ClinConnect ClinConnect Logo
Search / Trial NCT06302452

Adult Trauma Centers RE-AIM at Gun Safety

Launched by JOHNS HOPKINS UNIVERSITY · Mar 4, 2024

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Electronic Medical Record (EMR) Participants:
  • Inclusion Criteria:
  • trauma patients admitted to adult trauma inpatient services at participating institutions
  • Exclusion Criteria:
  • none
  • Patient participants
  • Inclusion Criteria:
  • at least 18 years of age;
  • admitted to a participating trauma service for an injury;
  • fluent in English or Spanish;
  • able to provide informed consent.
  • Exclusion Criteria:
  • prisoner or in police custody;
  • admitted due to suicide attempt
  • any acute conditions that would preclude provision of informed consent or assent (i.e., acute psychosis, altered mental status, cognitive impairment).
  • Staff participants
  • Inclusion Criteria:
  • trauma service physician, physician assistant, nurse practitioner, nurse or social worker at participating pediatric trauma center
  • Exclusion Criteria:
  • none

About Johns Hopkins University

Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.

Locations

Baltimore, Maryland, United States

Baltimore, Maryland, United States

Baltimore, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Katherine Hoops, MD, MPH

Principal Investigator

Johns Hopkins University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported